Both aggressive cancer cells and activated T cells secrete high levels of EDB-FN to promote invasion or migration, not by normal cells, providing a dynamic stromal marker which can be targeted by high-resolution MRMI for accurate detection of aggressive tumors as well as monitoring and prediction of treatment response 33, 41, 45. This evidence concerns the gene FN1 and cancer.